幹細胞治療の世界市場2018-2022...市場調査レポートについてご紹介

【英文タイトル】Global Stem Cell Therapy Market 2018-2022

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: PIPELINE ANALYSIS
• Pipeline analysis
PART 06: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 07: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 08: MARKET SEGMENTATION BY TYPE
• Segmentation by type
• Comparison by type
• Autologous transplants – Market size and forecast 2017-2022
• Allogeneic transplants – Market size and forecast 2017-2022
• Market opportunity by type
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Americas – Market size and forecast 2017-2022
• EMEA – Market size and forecast 2017-2022
• APAC – Market size and forecast 2017-2022
• Market opportunity
PART 11: MARKET SEGMENTATION BY APPLICATION
• Segmentation by application
PART 12: DECISION FRAMEWORK
PART 13: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 14: MARKET TRENDS
• Rise in costs
• Reimbursement
• Potential curative option for chronic diseases
• Development of iPS cells
PART 15: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 16: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Gilead
• Novartis
• Organogenesis
• Vericel
PART 17: APPENDIX
• List of abbreviations



Exhibit 01: Parent market
Exhibit 02: Global regenerative medicines market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: List of pipeline stem cell therapies
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2017
Exhibit 08: Validation techniques employed for market sizing 2017
Exhibit 09: Global stem cell therapy market – Market size and forecast 2017-2022 ($ mn)
Exhibit 10: Global stem cell therapy market – Year over year growth 2017-2022 (%)
Exhibit 11: Five forces analysis 2017
Exhibit 12: Five forces analysis 2022
Exhibit 13: Bargaining power of buyers
Exhibit 14: Bargaining power of suppliers
Exhibit 15: Threat of new entrants
Exhibit 16: Threat of substitutes
Exhibit 17: Threat of rivalry
Exhibit 18: Market condition – Five forces 2017
Exhibit 19: Global stem cell therapy market by type – Market share 2017-2022 (%)
Exhibit 20: Comparison by type
Exhibit 21: Global stem cell therapy market by autologous transplants – Market size and forecast 2017-2022 ($ mn)
Exhibit 22: Global stem cell therapy market by autologous transplants – Year over year growth 2017-2022 (%)
Exhibit 23: Global stem cell therapy market by allogeneic transplants – Market size and forecast 2017-2022 ($ mn)
Exhibit 24: Global stem cell therapy market by allogeneic transplants – Year over year growth 2017-2022 (%)
Exhibit 25: Market opportunity by type
Exhibit 26: Customer landscape
Exhibit 27: Global stem cell therapy market by region – Market share 2017-2022 (%)
Exhibit 28: Regional comparison
Exhibit 29: Stem cell therapy market in Americas – Market size and forecast 2017-2022 ($ mn)
Exhibit 30: Stem cell therapy market in Americas – Year over year growth 2017-2022 (%)
Exhibit 31: Top three countries in Americas
Exhibit 32: Stem cell therapy market in EMEA – Market size and forecast 2017-2022 ($ mn)
Exhibit 33: Stem cell therapy market in EMEA – Year over year growth 2017-2022 (%)
Exhibit 34: Top three countries in EMEA
Exhibit 35: Stem cell therapy market in APAC – Market size and forecast 2017-2022 ($ mn)
Exhibit 36: Stem cell therapy market in APAC – Year over year growth 2017-2022 (%)
Exhibit 37: Top three countries in Americas
Exhibit 38: Market opportunity
Exhibit 39: Types of accelerated approvals for stem cells
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Gilead overview
Exhibit 46: Gilead – Business segments
Exhibit 47: Gilead – Organizational developments
Exhibit 48: Gilead – Geographic focus
Exhibit 49: Gilead – Key offerings
Exhibit 50: Novartis overview
Exhibit 51: Novartis – Business segments
Exhibit 52: Novartis – Organizational developments
Exhibit 53: Novartis – Geographic focus
Exhibit 54: Novartis – Segment focus
Exhibit 55: Novartis – Key offerings
Exhibit 56: Organogenesis overview
Exhibit 57: Organogenesis – Product segments
Exhibit 58: Organogenesis – Organizational developments
Exhibit 59: Organogenesis – Key offerings
Exhibit 60: Vericel overview
Exhibit 61: Vericel – Business segments
Exhibit 62: Vericel – Organizational developments
Exhibit 63: Vericel – Key offerings


【レポート販売概要】

■ タイトル:幹細胞治療の世界市場2018-2022
■ 英文:Global Stem Cell Therapy Market 2018-2022
■ 発行日:2018年10月26日
■ 調査会社:Technavio
■ 商品コード:IRTNTR21031
■ 調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。